135 related articles for article (PubMed ID: 32814620)
1. ALK positive malignant peritoneal mesothelioma mimicking inflammatory myofibroblastic tumour: a diagnostic pitfall.
Louw A; Wallace C; Chai SM; Amanuel B; Wong DD
Pathology; 2020 Oct; 52(6):719-722. PubMed ID: 32814620
[No Abstract] [Full Text] [Related]
2. Peritoneal malignant mesothelioma: Slippery like an eel to diagnose on cytology-case series of 3 cases.
Gupta N; Soni A; Mahajan R; Selhi P; Tyagi R; Garg B; Kaur H
J Am Soc Cytopathol; 2022; 11(1):40-45. PubMed ID: 34602383
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Malignant Peritoneal Mesothelioma Mimicking an Autoinflammatory Syndrome in a 12-Year-Old Boy.
Olmedilla G; Undaondo C; Vasquez W; Rodriguez N
Pediatr Dev Pathol; 2021; 24(5):478-483. PubMed ID: 33872112
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal adenomatoid (microcystic) mesothelioma.
Mori D; Kido S; Hiraki M; Sumi K; Ureshino N; Masuda M; Nabeshima K; Akashi M
Pathol Int; 2020 Nov; 70(11):876-880. PubMed ID: 32881200
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum.
Loharamtaweethong K; Puripat N; Aoonjai N; Sutepvarnon A; Bandidwattanawong C
Histopathology; 2016 Mar; 68(4):603-7. PubMed ID: 26179668
[TBL] [Abstract][Full Text] [Related]
6. The value of BRCA-1-associated protein 1 expression and cyclin-dependent kinase inhibitor 2A deletion to distinguish peritoneal malignant mesothelioma from peritoneal location of carcinoma in effusion cytology specimens.
Althakfi W; Gazzo S; Blanchet M; Isaac S; Piaton E; Villeneuve L; Glehen O; Gilly FN; Brevet M
Cytopathology; 2020 Jan; 31(1):5-11. PubMed ID: 31713897
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal Mesothelioma Chronicles.
Fatima A; MacSweeney F; Riaz T; Heneghan J
Ir Med J; 2024 May; 117(5):964. PubMed ID: 38801147
[No Abstract] [Full Text] [Related]
8. Pediatric Malignant Peritoneal Mesothelioma With Meningeal Metastasis.
Aldrian D; Neu N; Oberhuber G; Kropshofer G; Müller T; Vogel GF
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e272-e274. PubMed ID: 33633025
[TBL] [Abstract][Full Text] [Related]
9. A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.
Miyagawa C; Takaya H; Sakai K; Nishio K; Konishi M; Minamiguchi S; Shimada T; Matsumura N
Oncologist; 2021 May; 26(5):356-361. PubMed ID: 33555117
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
11. Omental inflammatory myofibroblastic tumour mimicking peritoneal carcinomatosis.
Singhal M; Ramanathan S; Das A; Singh G; Bagga R; Khandelwal N
Cancer Imaging; 2011 Mar; 11(1):19-22. PubMed ID: 21435987
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!
Cordier F; Van der Meulen J; van Roy N; De Wilde J; van Dijck H; Vanhoenacker F; Lambrechts M; Noyez V; Van de Vijver K; Ferdinande L; Dendooven A; Van Dorpe J; Creytens D
Pathol Res Pract; 2022 Mar; 231():153772. PubMed ID: 35074700
[TBL] [Abstract][Full Text] [Related]
13.
Gerthofer V; Scheiter A; Lüke F; Keil F; Utpatel K; Pöhmerer LM; Seitz J; Niessen C; Ignatov A; Dietmaier W; Calvisi DF; Evert M; Ortmann O; Seitz S
JCO Precis Oncol; 2021; 5():. PubMed ID: 34568722
[No Abstract] [Full Text] [Related]
14. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology.
Nasit JG; Dhruva G
Am J Clin Pathol; 2014 Aug; 142(2):233-42. PubMed ID: 25015866
[TBL] [Abstract][Full Text] [Related]
15. Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report.
Hu J; Zhang B; Yao F; Fu Y; Chen D; Li D; Du N; Lizaso A; Song J; Zhang L; Li X
Ther Adv Respir Dis; 2020; 14():1753466620935770. PubMed ID: 32600123
[No Abstract] [Full Text] [Related]
16.
Bulutay P; Vatansever D; Taskiran C; Mericoz CA; Tokat F; Kapucuoglu N; Kulac I
Indian J Pathol Microbiol; 2023; 66(2):392-395. PubMed ID: 37077094
[TBL] [Abstract][Full Text] [Related]
17. [Malignant mesothelioma in the peritoneal cavity - a case report].
Rupert K; Třeška V
Rozhl Chir; 2015 Apr; 94(4):166-9. PubMed ID: 25866103
[TBL] [Abstract][Full Text] [Related]
18. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
[TBL] [Abstract][Full Text] [Related]
19. Diffuse malignant peritoneal mesothelioma.
Shih CA; Ho SP; Tsay FW; Lai KH; Hsu PI
Kaohsiung J Med Sci; 2013 Nov; 29(11):642-5. PubMed ID: 24183360
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant.
Shinozaki-Ushiku A; Kohsaka S; Kage H; Oda K; Miyagawa K; Nakajima J; Aburatani H; Mano H; Ushiku T
Pathol Int; 2020 Oct; 70(10):775-780. PubMed ID: 32583627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
